/ Weak Q4: Novartis India Plunges Over 4% ~ Ways2Capital|Stock Tips|Stock Market Tips|Intraday Stock Tips|Stock Trading Tips|NSE BSE Tips

Wednesday, 24 May 2017

Pharma player Novartis India stock dipped over 4% on BSE in Wednesday’s trade as the company posted its financials on 23 May 2017. The company’s net profit slumped 87.3% to Rs 2.91 crore on 12.4% decrease in net sales to Rs 145.48 crore in Q4 March 2017 over Q4 March 2016.

The stock opened its Wednesday’s trade at Rs 639.95 per share, touched a high of Rs 649.00 per share and a 52 week low of Rs 621.95 per share on BSE. Meanwhile, BSE Midcap index is trading weak over 137 points or nearly 1% at 14103.09 level with BSE Smallcap index dipped over 97 points in the pre-lunch session.   

Novartis India Limited manufactures drugs, medicines and allied products. The Company is engaged in the wholesale of pharmaceuticals and medical goods. The Company focuses on over three divisions, including pharmaceuticals, eye care and generic medicines. 

For Quick Trial – 8962000225 ✔
or mail us here: info@ways2capital.com
✆ - 0731-6626222 | Toll Free - 1800-3010-2007 
Give a Missed Call for Free Trial - 09699997717